Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group
Rev Assoc Med Bras (1992)
.
2024 Sep 30;70(10):e20240313.
doi: 10.1590/1806-9282.20240313.
eCollection 2024.
Authors
Helenice Gobbi
1
,
Filomena Marino Carvalho
2
,
Marina De Brot
3
,
Angela Flavia Logullo
4
,
Carlos Augusto Moreira Silva
5
,
Fernando Augusto Soares
6
,
Luciana Landeiro
7
,
Rosemar Rahal
8
,
Carlos Henrique Barrios
9
Affiliations
1
Universidade Federal do Triângulo Mineiro, Discipline of Special Pathology - Uberaba (MG), Brazil.
2
Universidade de São Paulo, Department of Pathology - São Paulo (SP), Brazil.
3
A.C.Camargo Cancer Center, Department of Pathological Anatomy - São Paulo (SP), Brazil.
4
Universidade Federal de São Paulo, Department of Pathology - São Paulo (SP), Brazil.
5
Institute of Molecular and Surgical Pathology - Ophir Loyola Hospital - Belém (PA), Brazil.
6
Universidade de São Paulo, Institute of Pathological Anatomy, School of Dentistry, D´Or São Luiz Network - São Paulo (SP), Brazil.
7
Oncoclínicas Group - Salvador (BA), Brazil.
8
Universidade Federal de Goiás, Department of Gynecology - Goiânia (GO), Brazil.
9
Latin American Cooperative Oncology Group and Oncoclínicas Group - Porto Alegre (RS), Brazil.
PMID:
39356956
PMCID:
PMC11444227
DOI:
10.1590/1806-9282.20240313
No abstract available
Publication types
Editorial
MeSH terms
Brazil
Breast Neoplasms* / genetics
Female
Humans
Practice Guidelines as Topic
Receptor, ErbB-2* / analysis
Substances
Receptor, ErbB-2
ERBB2 protein, human